EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Vagus Nerve Stimulation and Sacral Nerve Stimulation for Inflammatory Bowel Disease: A Systematic Review

Victor Pikov iD

Journal of Translational Gastroenterology · 25.12.2023 · 1 (2) · 94-100

DOI: 10.14218/jtg.2023.00098 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Translational Gastroenterology, online erschienen am 25.12.2023. Verfasst von Victor Pikov. Beteiligte Einrichtung: Medipace Inc, Pasadena, CA, USA. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives: In this systematic review, we assessed the efficacy, potential mechanisms, and safety of two neuromodulation therapies in patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. The first therapy is vagus nerve stimulation (VNS) utilizing implantable or transcutaneous electrodes, and the second is sacral nerve stimulation (SNS) using implantable or percutaneous electrodes.

Methods

We conducted a systematic literature review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The PubMed database was comprehensively searched, and studies were rigorously assessed for inclusion and exclusion criteria.

Results

Our analysis encompassed five clinical studies, three on VNS and two on SNS. Most investigated studies demonstrated significant beneficial effects on IBD symptoms, including disease activity, severity of intestinal lesions, and intestinal pain. When evaluating the impact on key IBD pathophysiologies, both VNS and SNS exhibited trends toward reducing biomarkers of intestinal mucosal inflammation and mitigating sympathetic dominance. Importantly, none of the evaluated neuromodulation methods resulted in long-term adverse effects.

Conclusions

Cumulative evidence from the evaluated studies indicates that VNS and SNS therapies effectively alleviate IBD symptoms and may hold promise in addressing the underlying pathophysiologies of IBD, including intestinal mucosal inflammation and sympathetic dominance. Consequently, they represent valuable options for individualized IBD treatment.

Schlagwörter

Stichwörter der Autor:innen

Crohn’s diseaseInflammatory bowel diseaseNeuromodulationSacral nerve stimulationUlcerative colitisVagus nerve stimulation

Autor:innen und Institutionen

  • Medipace Inc, Pasadena, CA, USA.

ORCID-Profile: Victor Pikov

Förderung

  • NINDS NIH HHS

Zitieren

APA

Pikov, V. (2023). Vagus Nerve Stimulation and Sacral Nerve Stimulation for Inflammatory Bowel Disease: A Systematic Review. Journal of Translational Gastroenterology, 1(2), 94-100. https://doi.org/10.14218/jtg.2023.00098

Vancouver

Pikov V. Vagus Nerve Stimulation and Sacral Nerve Stimulation for Inflammatory Bowel Disease: A Systematic Review. Journal of Translational Gastroenterology. 2023;1(2):94-100. doi:10.14218/jtg.2023.00098

BibTeX
@article{Pikov2023,
  author = {Pikov, Victor},
  title = {Vagus Nerve Stimulation and Sacral Nerve Stimulation for Inflammatory Bowel Disease: A Systematic Review},
  journal = {Journal of Translational Gastroenterology},
  year = {2023},
  volume = {1},
  number = {2},
  pages = {94--100},
  doi = {10.14218/jtg.2023.00098}
}
Kostenlos starten →